Marc Emery
Director, Program Management - Epigenetic Editing at Tune Therapeutics | Durham, North Carolina, United States
Marc Emery’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director, Program Management - Epigenetic Editing at Tune Therapeutics in April 2023 - Present
Associate Director, Program Management - Allogeneic Cell Therapy at Century Therapeutics in August 2019 - January 2023
Associate Director, Project Management - Gene Therapy at Gene Therapy Program | University of Pennsylvania in March 2018 - August 2019
Project Manager - Clinical IRT at Suvoda in August 2016 - March 2018
Technical Consultant at Labgistics Group in February 2016 - July 2016
Research Scientist - Bioassay & IVD at Arrayon Biotechnology SA in May 2013 - August 2015
Research Intern - Chemoembolization at ArchimMed in April 2012 - September 2012
Researcher - Genetic Engineering at Centro de Biologia Molecular e Engenharia Genética in January 2011 - November 2011
Hospital Intern at Edouard Herriot Hospital in June 2010 - August 2010
Student-Pharmacist at Grande Pharmacie de l'Ouest Lyonnais, Pharmacie des Gratte-ciels in January 2008 - January 2010
Research Trainee at INSERM Laboratory (UMR 863 - Steroid Hormones & Liaison Protein) in January 2008 - February 2008
The vast majority of human disease is governed by the epigenome, the subtle machinery that controls the volume of gene expression in cells. Tune Therapeutics is pioneering the creation of epi-therapeutic medicines with its powerful and precise epigenomic control platform, TEMPO. Unlike genome editing, TEMPO dials the volume of gene expression up or down towards healthy levels, without breaking or permanently rewriting DNA – and it can do this in multiple genes at once. This genetic tuning approach allows us to change cell fate and function at will, unlocking the ability to reverse pathways of cancer, genetic disease and aging. Our approach effectively expands the potential reach of genetic medicine – from targeting a limited range of rare conditions, to overcoming thousands of complex and chronic diseases that currently have no curative treatment.
Discover more about Tune Therapeutics
Immunologist - Cell and gene therapies, vaccines and infectious diseases
Director at Bristol Myers Squibb
(October 2024 – Present)
Vice President, Business Development at Tune Therapeutics
Vice President of Business Development at Tune Therapeutics
(September 2023 – Present)
Strategist, Storyteller, Science Communicator
Writer / Consultant at Murphy SciComm
(July 2003 – Present)
Associate Director, Facilities and Lab Operations at Tune Therapeutics
Assocuate Director at Tune Therapeutics
(July 2022 – Present)
Senior Scientist at Tune Therapeutics
Senior Scientist, Research Lead at Tune Therapeutics
(October 2022 – Present)
Facilities and Operations Management Professional
Director, Head of Facilities at Tune Therapeutics
(January 2022 – Present)
What is Marc Emery email address?
Email Marc Emery at [email protected], [email protected] and [email protected]. This email is the most updated Marc Emery's email found in 2026.
How to contact Marc Emery?
To contact Marc Emery send an email to [email protected], [email protected] or [email protected].
What company does Marc Emery work for?
Marc Emery works for Tune Therapeutics.
What is Marc Emery's role at Tune Therapeutics?
Marc Emery is Director, Program Management - Epigenetic Editing
What industry does Marc Emery work in?
Marc Emery works in the Biotechnology industry.
